Epidemiology and Treatment Modalities for the Management of Benign Prostatic Hyperplasia

    October 2019 in “ Translational Andrology and Urology ”
    Soum D. Lokeshwar, Benjamin T. Harper, Eric Webb … Zachary Klaassen
    Studysummary This review discusses current and emerging treatments for benign prostatic hyperplasia and emphasizes the need for further research to optimize treatment selection, but reports no new clinical results.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on tau.amegroups.com →
    Discuss this study in the Community →

    Research cited in this study 5

    1. Guidelines on the Use of Finasteride in Androgenetic Alopecia Indian Journal of Dermatology, Venereology and Leprology · 2016
    2. Current Pharmacological Treatment for Male LUTS Due to BPH: Dutasteride or Finasteride? Current Drug Targets · 2015
    3. Finasteride in the Treatment of Patients with Benign Prostatic Hyperplasia: A Review Therapeutics and Clinical Risk Management · 2009
    4. Comparison of Clinical Trials with Finasteride and Dutasteride PubMed · 2004
    5. The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia The New England Journal of Medicine · 2003